Mucormycosis
Mucor · Infectious Disease
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Mucormycosis is an aggressive angioinvasive mould infection (rhino-orbital-cerebral, pulmonary, cutaneous) affecting diabetics (ketoacidosis), haematology patients and the immunosuppressed. Survival depends on rapid surgical debridement, high-dose amphotericin and reversing predisposing factors.
Red flags
- Black necrotic eschar on palate/nasal mucosa
- Orbital/periorbital swelling, ophthalmoplegia, vision loss
- Altered consciousness (cerebral extension)
- Rapidly progressive necrosis
- Haemoptysis in pulmonary disease
Assessment
Differential diagnosis
- Invasive aspergillosis
- Bacterial orbital cellulitis/sinusitis
- Cavernous sinus thrombosis
- Malignancy
- Other invasive mould
Investigations
- Urgent CT/MRI of sinuses, orbit, brain or chest
- Tissue biopsy with histology (broad non-septate hyphae) and culture
- Blood glucose and ketones (diabetic ketoacidosis)
- Assess immunosuppression and iron-overload states
- Nasal endoscopy for black necrotic eschar
- Renal function before/during amphotericin
Management
- Suspect urgently in diabetic ketoacidosis or neutropenia with facial/sinus necrosis or refractory pneumonia
- Obtain emergent imaging and tissue biopsy for histology and culture
- Correct hyperglycaemia/ketoacidosis and reduce immunosuppression immediately
- Start high-dose liposomal amphotericin B without delay
- Arrange emergency surgical debridement of all necrotic tissue (often repeated)
- Stop deferoxamine and address iron overload if relevant
- Involve multidisciplinary team (ENT/ophthalmology/neurosurgery/ID)
- Monitor renal function and electrolytes on amphotericin
- Step down/add isavuconazole or posaconazole as appropriate
- Continue prolonged therapy guided by response
- Reassess with repeat imaging and surgical review
- Treat underlying condition to prevent relapse
Drugs & doses
Liposomal amphotericin B 5-10 mg/kg IV daily (first line, high dose)
Isavuconazole 200 mg (loading every 8 h x6 doses) then 200 mg daily (step-down/salvage)
Posaconazole (delayed-release) 300 mg daily after loading (salvage/oral step-down)
Insulin/fluids to correct diabetic ketoacidosis as adjunct
Disposition
Admit (critical); emergency surgery; multidisciplinary (ENT/neurosurgery/ID); ICU as needed.
Complications & pitfalls
- Cerebral invasion and stroke
- Vision loss and orbital destruction
- Dissemination
- Massive haemorrhage (pulmonary)
- High mortality despite treatment
Exam pearls
- Surgery plus high-dose amphotericin and metabolic correction is the triad for survival
- Voriconazole does not cover mucorales (and prior voriconazole is a risk factor)
- Reverse ketoacidosis and iron overload urgently
- Non-septate ribbon-like hyphae on histology distinguish from aspergillus
- Time to treatment strongly predicts survival - do not wait for culture
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.